Air Pollution and Pregnancy
- Disease/Condition
- Premature Birth
- Drug/Device/Intervention
- Policy
- Study type
- Observational
- Intervention type
- other
- Primary sponsor
- Queen Mary University of London
- Location
- London,London, United Kingdom
- Phase
- N/A
- Start date
- Sep 01, 2024
- End date
- Aug 31, 2029
- Enrollment
- 200000 participants
Machine learning model to predict the risk of preterm birth and adverse birth outcomes
We are an inter-disciplinary team of UK scientists with expertise in obstetrics, women's and
 child health, epidemiology, climate science, inflammation, computational modelling, machine
 learning and artificial intelligence. Together we have a long history with existing strengths
 underlying preterm birth research that crosses multiple disciplines and an excellent track
 record of publications and awards leading research in preterm birth.
 
 We aim to develop and validate a deep learning model to predict the risk of preterm birth and
 other adverse pregnancy outcomes using data from EPIC electronic health records at University
 College London Hospital Trust (UCLH) for a cohort of 18000 patients. We will obtain
 corresponding data on exposure to ambient pollution using non-identifiers for postcode (area)
 and date of delivery (month). The model will review the temporal sequence of events within a
 patient's medical history and current pregnancy, identifying significant interactions and
 will predict the risk of preterm birth. It will also determine the threshold and gestation at
 which pollution exposure has the greatest impact.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06340971
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06340971 through Pure Global AI's free database. This phase not specified trial is sponsored by Queen Mary University of London and is currently Recruiting. The study focuses on Premature Birth. Target enrollment is 200000 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.